Baebies, a medical device and diagnostics company in Durham, has received permission from the U.S. Food and Drug Administration to market a rapid, point-of-care test for the world’s most common enzyme deficiency.
Read More
The Durham-headquartered pediatric and newborn screening test company baebies, inc., has raised more than $37.5 million in new equity funding.
Read More
Baebies Inc., a medical device and diagnostics company in Durham, has received regulatory clearance to commercialize a test for the COVID-19 virus in Europe.
Read More
Durham-based newborn and pediatric screening company Baebies has raised nearly $12 million in debt funding from 87 investors.
Read More
Durham-based Baebies, which has delivered more than 10 million screening tests to using its technology for neonatal and pediatric patients, has amended a prior SEC filing, now showing 173 investors and more than $28.2 million raised.
Read More
Baebies will receive up to $11.6 million in non-dilutive funding to address neonatal and pediatric patients fighting sepsis.
Read More
Baebies, a Durham-based company specializing in disorder screening for newborns, has reached a company milestone of 10 million tests delivered to labs since its founding in 2014 that was bootstrapped by the North Carolina Biotechnology Center.
Read More
Baebies is winning kudos for its pediatric testing platform that uses one drop of blood to perform quick tests for multiple diseases. Here’s a look at what’s happening at the Durham startup.
Read More
Baebies, a biotech startup developing products and services for newborn screening and pediatric testing, has raised more than $18.7 million in equity.
Read More
